Cargando…
Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target
BACKGROUND: Neuroblastoma (NB) is an aggressive childhood malignancy in children up to 5 years of age. High-stage tumors frequently relapse even after aggressive multimodal treatment, and then show therapy resistance, typically resulting in patient death. New molecular-targeted compounds that effect...
Autores principales: | Yco, Lisette P., Geerts, Dirk, Mocz, Gabor, Koster, Jan, Bachmann, André S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475614/ https://www.ncbi.nlm.nih.gov/pubmed/26093909 http://dx.doi.org/10.1186/s12885-015-1447-y |
Ejemplares similares
-
Withaferin A Inhibits STAT3 and Induces Tumor Cell Death in Neuroblastoma and Multiple Myeloma
por: Yco, Lisette P, et al.
Publicado: (2014) -
Sepiapterin reductase: Characteristics and role in diseases
por: Wu, Yao, et al.
Publicado: (2020) -
Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy
por: Cronin, Shane J. F., et al.
Publicado: (2023) -
Sepiapterin reductase gene‐disrupted mice suffer from hypertension with fluctuation and bradycardia
por: Sumi‐Ichinose, Chiho, et al.
Publicado: (2017) -
Leaky splicing variant in sepiapterin reductase deficiency: Are milder cases escaping diagnosis?
por: Nakagama, Yu, et al.
Publicado: (2019)